Ascension Ventures
Ascension Ventures is a strategic healthcare venture capital firm founded in 2001, investing $10-$20M per company on behalf of 13 nonprofit healthcare system LPs that collectively operate 300+ hospitals across 22 states and manage over $1 billion in capital.
- Company typePrivate
- Founded2001
- HeadquartersSaint Louis, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ascension Ventures does
Ascension Ventures is a strategic healthcare venture fund and early-stage venture capital firm founded in 2001 and headquartered in St. Louis, Missouri. It pioneered the multi-system limited partner investment model in healthcare, aggregating commitments from 13 major nonprofit healthcare systems — including Ascension, AdventHealth, Intermountain Healthcare, Sentara, and Texas Health Resources — that collectively operate 300+ acute care hospitals, employ 453,000 associates, and generate $102 billion in annual revenue across 22 states and Washington, D.C.
The firm invests $10 to $20 million per company, typically taking a board seat or observation rights, and concentrates on early- to late-stage healthcare technology, medical devices/life sciences, and healthcare services companies. Its stated thematic focus areas — "Smarter Technologies, Bigger Data, Better Alternatives, Healthier Futures" — map onto a portfolio exceeding 70 companies spanning kidney care (Strive Health), precision medicine (Syapse), AI-driven diagnostics and process automation (Cofactor Genomics, Olive), patient engagement (Phreesia, GetWellNetwork), medical devices (RefleXion Medical, Cala Health, NextSense), and behavioral health (Mindpath Health, Owl). The firm does not build proprietary technology products; its competitive offering is strategic guidance, network access to LP hospital systems, and diligence informed by clinical and operational experience across its investment team.
Ascension Ventures generates returns primarily through capital appreciation and exits from its portfolio (with multiple historical liquidity events including the BioImagene acquisition by Roche/Ventana, MindFrame by Covidien, SeQual by Chart Industries, and TomoTherapy's IPO and later acquisition by Accuray), supplemented by standard VC management fees on greater than $1 billion in capital under management. The firm deploys a sales-led, referral-driven deal sourcing model — direct outreach from healthcare innovators and networking through LP health systems — and operates a restricted partner portal for LP document distribution.
Ascension Ventures firmographics
Firmographics- Name
- Ascension Ventures
- Legal name
- Ascension Ventures
- Website
- http://ascensionventures.org/
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ascension Ventures is a strategic healthcare venture capital firm founded in 2001, investing $10-$20M per company on behalf of 13 nonprofit healthcare system LPs that collectively operate 300+ hospitals across 22 states and manage over $1 billion in capital.
- Ownership category
- akta.pro rank
Ascension Ventures industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Ascension Ventures is headquartered
LocationHeadquarters
- HQ city
- Saint Louis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ascension Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Fund Management: Ascension Ventures operates as a venture capital fund, generating returns through capital appreciation and exits from portfolio companies. The fund has more than $1 billion in capital under management and serves limited partners consisting of major healthcare systems.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Ascension Ventures product offering
Product offeringCore offering
Ascension Ventures is a strategic healthcare venture capital fund that makes equity investments of $10-$20 million per company in early- to late-stage healthcare IT, medical device, and healthcare services companies. With more than $1 billion in capital under management, the firm manages a diversified portfolio companies and serves as a multi-system Limited Partner platform connecting 13+ nonprofit healthcare systems with healthcare innovators. The firm provides portfolio companies with strategic guidance, often requesting board seats or observation rights, and access to a network of 300+ acute care hospitals and 453,000 associates across 22 states.
Product overview
Ascension Ventures is a strategic healthcare venture fund with over $1 billion in capital under management. The firm does not develop or sell its own technology products; instead, it maintains a diversified portfolio of healthcare companies across healthcare services, medical technology/life sciences, and healthcare IT sectors. The portfolio includes companies focused on telemedicine platforms (Zipnosis), AI/healthcare automation (Olive, Censys), precision medicine (Syapse, Cofactor Genomics), medical devices (RefleXion Medical, Cala Health, NextSense), patient engagement (GetWellNetwork, Phreesia), diagnostics (Bardy Diagnostics, HealthMyne), kidney care (Strive Health), behavioral health (Owl, Mindpath Health), and various other healthcare technology and service offerings. The fund serves as a strategic investment vehicle for healthcare systems seeking to participate in healthcare innovation.
Differentiator
Problem solved
Functional benefit
Products and services
- Partner Portal
- Strategic Healthcare Venture Capital Fund
Quantifiable outcome
- More than $1 billion in capital under management
- +2 more outcomes
Companies that use Ascension Ventures
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
Ascension Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ascension Ventures partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights5 records
Ascension Ventures competitors and assessment
Company assessmentBroad incumbents
- OrbiMed: Healthcare-dedicated investment firm across private equity, venture, and royalty/credit; broader incumbent with deeper healthcare specialization across stages, partially overlapping medtech and healthcare services focus.
- Optum Ventures: Venture capital arm of Optum/UnitedHealth Group making strategic healthcare technology investments at scale; broader incumbent with much larger AUM and capacity, but overlapping thesis in digital health, value-based care, and healthcare AI.
- General Catalyst (Health Assurance): Large multi-stage venture firm with a dedicated Health Assurance thesis and health system partnerships; broader incumbent with greater scale and longer fund vintages, but overlapping healthcare mandate and investor model.
- Andreessen Horowitz (Bio + Health Fund): Major venture firm with dedicated bio/healthcare funds investing across healthcare services, digital health, and life sciences; broader incumbent with deeper capital base, overlapping investment categories though generally at different stages.
Direct peers
- Echo Health Ventures: Strategic healthcare venture capital platform backed by multiple health systems, with a similar multi-LP structure and focus on early- to growth-stage healthcare investments; directly comparable as a strategic healthcare-system-affiliated investor.
- Providence Ventures: Venture capital arm of Providence Health system making strategic healthcare investments; highly comparable as a single-system-affiliated strategic healthcare VC with similar investment criteria and value-add through clinical validation.
- HealthX Ventures: Wisconsin-based early-stage digital health venture capital firm focused on healthcare technology; directly comparable as a healthcare-focused early-stage VC where AV's Taha Jangda was previously a General Partner.
- .406 Ventures: Boston-based early-stage venture capital firm with a dedicated healthcare practice investing in healthcare IT, services, and medical devices; comparable in stage, check size, and healthcare focus.
- Kaiser Permanente Ventures: Strategic venture capital arm of Kaiser Permanente, one of the largest US nonprofit health systems; directly comparable as a health-system-affiliated strategic investor in early- to growth-stage healthcare companies.
- Memorial Hermann Innovation: Innovation and venture arm of Memorial Hermann Health System making strategic investments in healthcare technology companies; directly comparable as a single-system-affiliated strategic healthcare investor with similar model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights5 records
Customer concentration
Ascension Ventures social profiles
Digital presenceAscension Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ascension Ventures leadership team
Management profileNumber of profiles
Profiles12 records
Ascension Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ascension Ventures M&A and investment
M&A and investmentM&A
Investments108 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ascension Ventures
What does Ascension Ventures do?
Ascension Ventures is a strategic healthcare venture capital fund that makes equity investments of $10-$20 million per company in early- to late-stage healthcare IT, medical device, and healthcare services companies. With more than $1 billion in capital under management, the firm manages a diversified portfolio companies and serves as a multi-system Limited Partner platform connecting 13+ nonprofit healthcare systems with healthcare innovators. The firm provides portfolio companies with strategic guidance, often requesting board seats or observation rights, and access to a network of 300+ acute care hospitals and 453,000 associates across 22 states.
Is Ascension Ventures a public or private company?
Ascension Ventures is a private company. It is classified as corporate owned and is currently operating.
When was Ascension Ventures founded?
Ascension Ventures was founded in 2001. It employs 11 to 50 people.
Where is Ascension Ventures based?
Ascension Ventures is headquartered in Saint Louis, United States, in the North America region.
How does Ascension Ventures make money?
One revenue line is on record: fund Management.
Who are Ascension Ventures's main competitors?
Broad incumbents on record are OrbiMed, Optum Ventures, General Catalyst (Health Assurance) and Andreessen Horowitz (Bio + Health Fund). Direct peers are Echo Health Ventures, Providence Ventures, HealthX Ventures, .406 Ventures, Kaiser Permanente Ventures and Memorial Hermann Innovation.
Does Ascension Ventures have an API?
No public API is recorded for Ascension Ventures.
What industry is Ascension Ventures in?
Ascension Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.